Inflammatory response in visceral fat tissue and liver is prenatally programmed: Experimental research

Journal of Physiology and Pharmacology

Volumn 66, Issue 1, 2015, Pages 57-64

  Bezpalko, L ^a   Gavrilyuk, O ^a   Zayachkivska, Oksana ^a  

^a DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Adiponectin; Adipose tissue; Diet; Inetrleukin 1 ; Inflammatory process; Interleukin 8; Leptin; Lifestyle; Liver; Obesity; Stress

Indexed keywords

ADIPONECTIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEPTIN; ADIPOCYTOKINE; AUTACOID; CARBOHYDRATE DIET; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; INFLAMMATION; INTRAABDOMINAL FAT; LIVER CELL; LIVER CELL DAMAGE; MALE; MATERNAL STRESS; MICROSCOPY; MOTHER FETUS RELATIONSHIP; NONHUMAN; RAT; VISUAL ANALOG SCALE; ADVERSE EFFECTS; ANIMAL; ANIMAL FOOD; BLOOD; CARBOHYDRATE DIET; COMPLICATION; EATING; IMMUNOLOGY; LIPID DIET; LIVER; MATERNAL NUTRITION; MENTAL STRESS; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; SEVERITY OF ILLNESS INDEX;

ADIPOKINES; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; CYTOKINES; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; EATING; FEMALE; INFLAMMATION; INFLAMMATION MEDIATORS; INTRA-ABDOMINAL FAT; LIVER; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NON-ALCOHOLIC FATTY LIVER DISEASE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 84923141640     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Lappalainen T. Obesity, low-grade inflammation and cardiovascular diseases - special emphasis on fat mass and obesity associated (FTO) and serum amyloid A (SAA) Genes. Publications of the University of Eastern Finland. Dissertations in Health Sciences, Kuopio. 2010.
2. Duvnjak L., Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol 2009; 60 (Suppl. 7): 19-24.
3. Konturek PC, Konturek SJ, Brzozowski T, Hahn EG. Gastroprotection and control of food intake by leptin. Comparison with cholecystokinin and prostaglandins. J Physiol Pharmacol 1999; 50: 39-48.
4. Tanti JF, Ceppo F, Jager J, Berthou F. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne) 2012; 3: 181.
5. Krawczynska A, Olczak E, Rembiszewska A, Herman AP, Gromadzka-Ostrowska J. Time-dependent supplementation of vitamin E influences leptin expression in the aortic layers of rats fed atherogenic diet. J Physiol Pharmacol 2014; 65: 33-39.
6. Zelber-Sagi S, Ratziu V, Zvibel I, et al. The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population. Eur J Gastroenterol Hepatol 2012; 24: 262-269.
7. Wang Z, Yao T, Pini M, Zhou Z, Fantuzzi G, Song Z. Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2010; 298: G634-G642.
8. Farell GC, van Rooyen D, Gan L, Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 2012; 6: 149-171.
9. Adams LA, Harmsen S, St Sauver JL, et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 2010; 105: 1567-1573.
10. Vos MB, Welsh J. Prevalence of suspected NAFLD is increasing among U.S. adolescents. Gastroenterology 2012; 5 (Suppl. 1) abstract 705.
11. Deierlein AL, Siega-Riz AM, Adair LS, Herring AH. Effects of prepregnancy body mass index and gestational weight gain on infant anthropometric outcomes. J Pediatr 2011; 158: 221-226.
12. Nicoletto SF, Rinaldi A. In the womb's shadow: the theory of prenatal programming as the fetal origin of various adult diseases is increasingly supported by a wealth of evidence. EMBO Rep 2011; 12: 30-34.
13. Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of "metabolic memory". Exp Diabetes Res 2011; 2011: 218598.
14. Tarry-Adkins LJ, Ozanne ES. Mechanisms of early life programming: current knowledge and future directions. Am J Clin Nutr 2011; 94 (Suppl. 6): 1765S-1771S.
15. Nivoit P, Morens C, Van Assche FA, et al. Established dietinduced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance. Diabetologia 2009; 52: 1133-1142.
16. Method of induction the hepatocellular reorganization in offspring of experimental animals at the term of prenatal programming. Patent No 81947. UA, G09B 23/28, G01N 33/ 48. No request u 2013 02294 (25.02.2013). Published 10.07.2013, Bul. No 13, 2013./Co-authors: L. Bezpalko, O. Zayachkivska, M. Gzhegotsky.
17. Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18: 6546-6551.
18. Kotsumbas IY. Preclinical Researches of Medications in Veterinary Science. Lviv, Triada Plus, 2006.
19. Pratt NC, Lisk RD. Effects of social stress during early pregnancy on litter size and sex ratio in the golden hamster (Mesocricetusauratus). J Reprod Fertil 1989; 87: 763-769.
20. Kozar VV, Kudria MY, Ustenko NV, Pavlenko TO, Zhurakovs'ka MV. The state of the humoral component of immunity under condition of metabolic syndrome with underlying hypoestrogenia and farmacological correction. Buk Med Herald 2009; 13: 141-144.
21. Verhulst PJ, Lintermans A, Janssen S, et al. GPR39, a receptor of the ghrelin receptor family, plays a role in the regulation of glucose homeostasis in a mouse model of early onset diet-induced obesity. J Neuroendocrinol 2011; 23: 490-500.
22. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
23. Bezpalko L, Gavrylyuk O, Zayachkivska O, Gzhegotskiy M. Role of metabolic stress in process of cellular reorganization of liver (experimental research). Tavricheskiy Medicko- Biologicheskiy Vestnik 2012; 1: 301-302.
24. Nov O, Shapiro H, Ovadia H, et al. Interleukin-1 regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability. PLoS One 2013; 8: e53626.
25. Sawyer FS. Analysis of variance: the fundamental concepts. J Manual Manipulative Ther 2009; 17: E27-E38.
26. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 2012; 56: 952-964.
27. Suganami T, Tanaka M, Ogawa Y. Adipose tissue inflammation and ectopic lipid accumulation. Endocr J 2012; 59: 849-857.
28. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
29. Gu JJ, Gao FY, Zhao TY. A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats. J Physiol Pharmacol 2012; 63: 505-513.
30. Oh DY, Morinaga H, Talukdar S, Bae EJ, Olefsky JM. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012; 61: 346-354.
31. Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008; 29: 274-281.
32. Sarr O, Yang K, Regnault TR. In utero programming of later adiposity: the role of fetal growth restriction. J Pregnancy 2012; 2012: 134758.
33. Rius B, Lopez-Vicario C, Gonzalez-Periz G, et al. Resolution of inflammation in obesity-induced liver disease. Front Immunol 2012; 3: 257.
34. Freeman DJ. Effects of maternal obesity on fetal growth and body composition: implications for programming and future health. Semin Fetal Neonatal Med 2010; 15: 113-118.
35. Vuguin PM, Hartil K, Kruse M, et al. Shared effects of genetic and intrauterine and perinatal environment on the development of metabolic syndrome. PLoS One 2013; 8: e06302.
36. Fall CH. Evidence for the intra-uterine programming of adiposity in later life. Ann Hum Biol 2011; 38: 410-428.
37. Hyatt MA, Gardner S, Sebert S, et al. Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring. Reproduction 2011; 141: 119-126.
38. Stanton MC, Chen S-C, Jackson JV, et al. Inflammatory signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflamm (Lond) 2011; 8: 8. doi: 10.1186/1476-9255-8-8.
39. Touwslager RN, Gielen M, Mulder AL, et al. Changes in genetic and environmental effects on growth during infancy. Am J Clin Nutr 2011; 94: 1568-1574.
40. Heindel JJ, vom Saal FS. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the etiology of obesity. Mol Cell Endocrinol 2009; 304: 90-96.
41. Benklaft NB, Merzouk H, Bouanane S, et al.Altered adipose tissue metabolism in offspring of dietary obese rat dams. Clin Sci 2011; 121: 19-28.
42. Gluckman PD, Hanson MA. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Int J Obes 2008; 32 (Suppl. 7): S62-S71.
43. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001; 60: 5-20.
44. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Eng J Med 2008; 359: 61-73.
45. Gotoh K, Inoue M, Masaki T. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity induced inflammation in white adipose tissue and liver. Diabetes 2012; 61: 1994-2003.
46. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
47. Kondro M, Gzhegotsky M, Zayachkivska O, Gavryluk O. Analyses activity system NO/NOS by result of specifics in liver structural and functional changes under the conditions of individual and complex persistent effect of lead acetate in various dosages and stress. Pract Med 2008; 1 (Suppl. 14): 82-92.
48. Duval C, Thissen U, Keshtkar S, et al. Adipose tissue disfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57Bl/6 Mice. Diabetes 2010; 59: 3181-3191.
49. Fernandez-Twinn DS, Ozanne SE. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006; 88: 234-243.
50. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE. Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Reg Integr Comp Physiol 2010; 299: R711-R722.
51. McCurdy CE, Bishop JM, William SM, et al. A Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009; 119: 323-335.